CryoCath Technologies Acquired by Medtronic
TM Capital advised CryoCath Technologies (TSX: CYT) in its sale to Medtronic, Inc. (NYSE: MDT) for a C$425mm enterprise value in an all-cash takeover bid
Immucor Acquires Gamma Biologicals
TM Capital assisted Immucor, Inc. (NASDAQ) in completing the $30 million acquisition of Gamma Biologicals, Inc. (AMEX) via a cash tender offer
Sapheon Acquired by Covidien plc
TM Capital served as exclusive financial advisor to Sapheon Inc., a developer of venous disease treatments, in its sale to Covidien plc, a world leader in the treatment of peripheral vascular disease, for up to $238 million in cash and contingent consideration
InNeuroCo has been Acquired by Integer
TM Capital served as exclusive financial advisor to InNeuroCo in its sale to Integer Holdings Corporation